There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abbott Laboratories (ABT – Research Report) and ...

Abbott Laboratories closed 10.57% short of its 52-week high of $141.23, which the company reached on March 4th.

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Abbott Laboratories closed 2.90% short of its 52-week high of $141.23, which the company achieved on March 4th.

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Abbott Laboratories (ABT – Research ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 10 trades. If we consider the ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other Friday’s worst performing stocks. Wall Street’s main indices bounced back on Friday ...

In contrast to all that, many investors prefer to focus on companies like Abbott Laboratories (NYSE:ABT), which has not only revenues, but also profits. Now this is not to say that the company ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...